SUSAN HILSENBECK to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications SUSAN HILSENBECK has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.061
-
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer. Ann Oncol. 2019 06 01; 30(6):927-933.
Score: 0.036
-
Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells. J Pathol. 2014 Jan; 232(1):75-86.
Score: 0.025